Exploring Long-Term Adherence Markers Using Hair and Dried Blood Spots in iPrEX OLE
Background: Adherence to tenofovir/emtricitabine (TFV/FTC)-based PrEP is critical to efficacy. The limitations of self-reported adherence in reliably capturing TFV/FTC exposure are well-known, raising interest in pharmacologic measures where drug levels are assessed in a biomatrix (e.g. plasma, peripheral blood mononuclear cells (PBMCs), dried blood spots (DBS), hair). Plasma and PBMC collection can be challenging, require…